IMMUNOCOMPROMISED

Clinical trials for IMMUNOCOMPROMISED explained in plain language.

Never miss a new study

Get alerted when new IMMUNOCOMPROMISED trials appear

Sign up with your email to follow new studies for IMMUNOCOMPROMISED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Terminated 1

Antibody shield for the vulnerable: COVID-19 prevention trial in immunocompromised

Prevention Terminated

This study tested whether a combination of antibodies (casirivimab+imdevimab) could prevent COVID-19 in people with weakened immune systems, such as transplant recipients or cancer patients. Participants received either the antibodies or a placebo as a shot under the skin. The tr…

Matched conditions: IMMUNOCOMPROMISED

Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention

Last updated Jun 27, 2026 07:55 UTC

IMMUNOCOMPROMISED

Get alerted when new IMMUNOCOMPROMISED trials appear

Antibody shield for the vulnerable: COVID-19 prevention trial in immunocompromised